Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 16, 2020

Primary Completion Date

October 13, 2020

Study Completion Date

October 13, 2020

Conditions
COVID-19Hypoxia
Interventions
DRUG

L-ascorbic acid

50 mg/kg L-ascorbic acid infusion given every 6 hours for 4 days (16 total doses)

Trial Locations (1)

23249

Hunter Holmes Mcguire Veteran Affairs Medical Center, Richmond

Sponsors
All Listed Sponsors
collaborator

McGuire Research Institute

OTHER

lead

Hunter Holmes Mcguire Veteran Affairs Medical Center

FED